AbbVie (ABBV) EV to FCF (2012 - 2026)
AbbVie's (ABBV) quarterly EV to FCF came in at 140.71 in Q2 2026, up 113.76% year-over-year from 65.82 in Q2 2025, and up 33.76% quarter-over-quarter from 105.19 in Q1 2026.
Analysis
AbbVie (ABBV) EV to FCF (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported EV to FCF for 15 consecutive years, with 140.71 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to FCF rose 113.76% year-over-year to 140.71 in Q2 2026; TTM through Jun 2026 was 24.06, a 36.51% increase from a year earlier, with the FY2025 full-year figure at 22.38, up 29.52% from the prior year.
- EV to FCF was 140.71 for Q2 2026 at AbbVie, up from 105.19 in the prior quarter.
- Over five years, EV to FCF peaked at 260.69 in Q1 2025 and troughed at 30.37 in Q3 2022.
- A 5-year average of 79.22 and a median of 63.25 in 2024 frame the typical range for EV to FCF.
- Across the five-year window, EV to FCF soared 282.78% in 2024 and sank 59.65% in 2026, its largest moves.
- Over 5 years, EV to FCF stood at 38.36 in 2022, then soared by 49.59% to 57.38 in 2023, then fell by 20.51% to 45.61 in 2024, then soared by 78.84% to 81.57 in 2025, then surged by 72.5% to 140.71 in 2026.
- The last three EV to FCF figures came in at 140.71 (Q2 2026), 105.19 (Q1 2026), and 81.57 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 140.71 |
| Mar 31, 2026 | 105.19 |
| Dec 31, 2025 | 81.57 |
| Sep 30, 2025 | 60.75 |
| Jun 30, 2025 | 65.82 |
| Mar 31, 2025 | 260.69 |
| Dec 31, 2024 | 45.61 |
| Sep 30, 2024 | 65.74 |
| Jun 30, 2024 | 142.78 |
| Mar 31, 2024 | 78.90 |
| Dec 31, 2023 | 57.38 |
| Sep 30, 2023 | 33.98 |
| Jun 30, 2023 | 37.30 |
| Mar 31, 2023 | 68.31 |
| Dec 31, 2022 | 38.36 |
| Sep 30, 2022 | 30.37 |
| Jun 30, 2022 | 53.66 |
| Mar 31, 2022 | 58.77 |
| Dec 31, 2021 | 46.99 |
| Sep 30, 2021 | 23.13 |